---
$id: https://graph.org.ai/products/commodity/51281640
$type: Product
source: UNSPSC
code: "51281640"
title: "Capreomycin ib"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Capreomycin ib

**UNSPSC Code**: 51281640
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula C25H44N14O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2YP3RYC823, chemically known as cyclo((2s)-2-amino-.beta.-alanyl-l-alanyl-3-(((3s)-3,6-diamino-1-oxohexyl)amino)-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl), but more generally known as capreomycin ib, which bears US NIH Compound Identifier 3034057. European Medicines Agency schedules capreomycin ib or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01028MIG. Most nations, for tariff purposes, schedule capreomycin ib under HS 29419000. SMILES: C[C@H]1C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N.

